chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Blood creatine phosphokinase increased, Chest X-ray normal, Chest discomfort, Chest pain
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Chills, Dyspnoea, Echocardiogram normal, Electrocardiogram normal, Hyperhidrosis
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Oropharyngeal pain, Productive cough, Pyrexia, Troponin I increased
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB normal, Chest X-ray normal, Chest discomfort, Chest pain, Chills
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Differential white blood cell count normal, Dyspnoea, Electrocardiogram normal, Full blood count normal, Hyperhidrosis
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Metabolic function test normal, Myocarditis, Oropharyngeal pain, Productive cough, Pyrexia
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin increased
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB normal, Blood creatine phosphokinase increased, Blood creatine phosphokinase normal, Chest X-ray normal, Chest discomfort
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Chest pain, Chills, Dyspnoea, Echocardiogram normal, Electrocardiogram normal
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Hyperhidrosis, Oropharyngeal pain, Productive cough, Pyrexia, Troponin increased
Clinical narrative: This unsolicited case was received on 06-Sep-2016 via a third party query tool search on the VAERS database, under reference number 634295. This case involves a 20-years old male patient who received the following vaccinations on 21-April-2016: A first dose of ACAM2000, lot number-VV03019C, manufacturer: Sanofi Pasteur Biologics Co. in the left arm via intradermal and third dose of BIOTHRAX, lot number- FAV459A, manufacturer: Baxter Healthcare Corporation (route and site reported as unknown). Patient's medical history and current illnesses were reported as none. Concomitant medications was not reported. On 02-May-2016, 11 days post vaccination, the patient experienced dull substernal chest pain and tightness with SOB (difficulty taking deep breaths) (dyspnoea) with subjective fevers & chills, mild sweating, sore throat, mild intermittent cough with clear mucus, hyperhidrosis, oropharyngeal pain and pyrexia. On an unspecified date, the patient was hospitalized (emergency visit). Laboratory investigations includes elevated cardiac markers (CK, CK-MB, and Troponin-I), electrocardiogram normal, chest x-ray normal, echocardiogram normal. Also reported as blood creatine phosphokinase MB, blood creatine phosphokinase and troponin increased. Corrective treatments were not reported. On an unspecified date, the patient was recovered from the events. List of documents held by sender: none. Sender's Comments: This case concerns 20 year old male patient who received SMALLPOX (VACCINIA) LIVE VACCINE simultaneously with ANTHRAX VACCINE. Twelve days after the vaccination patient developed chest discomfort/chest tightness, chest pain, chills, dyspnoea/SOB, hyperhidrosis/mild sweating, oropharyngeal pain/sore throat, productive cough/mild intermittent cough with clear mucus and pyrexia, laboratory data on enzymes suggest underlying cardiovascular disorder. Time to onset is compatible, but additional information on patient's medical history, tolerance of previous vaccinations, concomitant medications, condition at the time of vaccination, investigation results ruling out a concurrent infection, etc. are needed to further assess the case. As two vaccine are administered the role of each vaccine cannot be assessed.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Abasia, Activities of daily living impaired, Asthenia, Back pain, Computerised tomogram normal
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Decreased appetite, Headache, Hypoaesthesia, Injection site pain, Intensive care
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Lumbar puncture, Nausea, Neck pain, Nuclear magnetic resonance imaging normal, Paraesthesia
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Post lumbar puncture syndrome, Pyrexia, Viral infection, Visual impairment
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: CSF glucose normal, CSF protein normal, CSF red blood cell count positive, CSF white blood cell count negative, Computerised tomogram head normal
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Eye pain, Gram stain negative, Haematocrit normal, Haemoglobin normal, Headache
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Injection site swelling, Metabolic function test, Mononucleosis heterophile test negative
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Muscular weakness, Nausea, Nuclear magnetic resonance imaging brain, Nuclear magnetic resonance imaging spinal, Paraesthesia
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Phonophobia, Photophobia, Platelet count normal, Pyrexia, Reflex test normal
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Vision blurred, Wheelchair user, White blood cell count normal
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Blood test normal, Computerised tomogram normal, Fatigue, Feeding disorder, Headache
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Hemiparesis, Lumbar puncture normal, Malaise, Migraine, Mononucleosis heterophile test negative
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Muscular weakness, Nausea, Nuclear magnetic resonance imaging normal, Pain, Paraesthesia
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Pyrexia, Vision blurred, Visual impairment, Weight decreased
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Blood test, Computerised tomogram, Electroencephalogram, Electromyogram, Lumbar puncture
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 16.0
Sex: F
Vaccine: MENB, MENB, MENB, MENB
Symptoms: Migraine, Nuclear magnetic resonance imaging, Paraesthesia, Scan with contrast, Vision blurred
Clinical narrative: Migraine, with blurred vision, tingling on her left side all the way to her toes.
Age: 46.0
Sex: F
Vaccine: FLU4, PPV, FLU4, PPV
Symptoms: Altered state of consciousness, Arthralgia, Back pain, Dizziness, Ear pain
Clinical narrative: Swelling at injection site, rash on arm severe arm pain, severe exhaustion, muscle aches, fever, headache, dizziness, ear pain.
Age: 46.0
Sex: F
Vaccine: FLU4, PPV, FLU4, PPV
Symptoms: Erythema, Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Swelling at injection site, rash on arm severe arm pain, severe exhaustion, muscle aches, fever, headache, dizziness, ear pain.
Age: 46.0
Sex: F
Vaccine: FLU4, PPV, FLU4, PPV
Symptoms: Peripheral swelling, Pyrexia, Rash, Skin warm
Clinical narrative: Swelling at injection site, rash on arm severe arm pain, severe exhaustion, muscle aches, fever, headache, dizziness, ear pain.
Age: 46.0
Sex: F
Vaccine: FLU4, PPV, FLU4, PPV
Symptoms: Dizziness, Ear pain, Fatigue, Injection site swelling, Myalgia
Clinical narrative: Swelling at injection site, rash on arm severe arm pain, severe exhaustion, muscle aches, fever, headache, dizziness, ear pain.
Age: 46.0
Sex: F
Vaccine: FLU4, PPV, FLU4, PPV
Symptoms: Pain in extremity, Pyrexia, Rash
Clinical narrative: Swelling at injection site, rash on arm severe arm pain, severe exhaustion, muscle aches, fever, headache, dizziness, ear pain.
Age: 78.0
Sex: F
Vaccine: FLUX
Symptoms: Allergy test positive, Anaphylactic reaction, Drug hypersensitivity, Feeling abnormal
Clinical narrative: Case PHEH2016US023299, is an initial spontaneous report received from a consumer on 12 Sep 2016. This report refers to a 78 years old female patient. Medical history and the patient current condition was included as neomycin antibiotic allergy. Concomitant medications were not reported. The patient was vaccinated with single dose of seasonal influenza vaccine (manufacturer unknown, batch number: not reported) on an unknown date. The consumer stated that, long time ago she received a flu vaccine (not specified) and almost died because of it. The patient experienced anaphylactic reaction to vaccine. Later after an allergy test (unspecified), it was discovered that she was allergic to neomycin and antibiotics (unspecified). The outcome of the event anaphylactic reaction was reported as complete recovery on an unknown date and for other events was not reported. The seriousness of the events was not reported by the consumer. The causality of the events was not reported. The seriousness assessment of the event feeling abnormal was upgraded based on information available in the source document. The seriousness assessment of the event anaphylactic reaction was upgraded to medically significant based on the Novartis Important Medical Event list. The case is lost to follow up at initial.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Vomiting
Clinical narrative: This is a spontaneous report from a contactable nurse received via a Pfizer sales representative.  This nurse reported similar events in two patients. This is the first of two reports.  A 17-year-old male patient of an unspecified ethnicity received the first dose of TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunisation.  The patient's medical history and concomitant medications were not reported.  On an unknown date, the next day after the vaccination, the patient experienced vomiting. The clinical outcome of the event, vomiting, was unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2016424808 same reporter, drug, event in a different patient.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Vomiting
Clinical narrative: This is a spontaneous report from a contactable nurse received via a Pfizer sales representative.  This nurse reported similar events in two patients. This is the second of two reports.  A 17-year-old female patient of an unspecified ethnicity received the first dose of TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunisation.  The patient's medical history and concomitant medications were not reported.  On an unknown date, the next day after the vaccination, the patient experienced vomiting. The clinical outcome of the event, vomiting, was unknown. Sender's Comments: Linked Report(s) : US-PFIZER INC-2016424799 same reporter, drug, event in a different patient.
Sex: F
Vaccine: MENB
Symptoms: Full blood count, Platelet count decreased
Clinical narrative: This is a spontaneous report from a contactable consumer, reporting for his daughter. A 21-year-old female patient received TRUMENBA, via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient had no medical history or concomitant medications. On an unknown date in Sep2016, the patient's platelet count dropped after recently receiving meningococcal group b rlp2086. On an unknown date, the patient had a full blood count, the results of which were not provided. On an unknown date, prior to vaccination, the platelet count was "200,000".  On an unknown date in Sep2016, after the vaccination, the platelet count dropped down to "6000". Therapeutic measures were taken as a result of the event and included treatment with prednisone, which was not working. The clinical outcome of the event, platelet count dropped after recently receiving meningococcal group b rlp2086, was not recovered and was reported as getting worse.
Sex: M
Vaccine: DTAP
Symptoms: Vaccination complication
Clinical narrative: Initial unsolicited report received from a pharmacist on 08-Sep-2016. This case involves a male patient (age unknown) who was vaccinated with DTAP (lot number, expiration date, dose, dose in series, route of administration not reported) on an unknown date. The medical history and concomitant medications were reported as unknown. On an unknown date, after vaccination, patient experienced bad reaction. Laboratory data and corrective treatment was not reported. Patient had recovered from event on an unknown date. List of the documents held by sender: none.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Fatigue, Headache, Injection site pain, Lymphadenopathy
Clinical narrative: It started Thursday (09/15/16) evening with a headache and by Friday 09/16/16)morning, I had a sore throat, headache, fever (from 99.9-101), nauseous, sore joints, injection site/shoulder pain, extreme fatigue/sleepiness and achy all over.  Even my eyelashes hurt!   Saturday (09/17/16) at 830pm I started to feel better.  I still had a slight headache but no fever and the achiness was mostly gone.  The injection site/shoulder pain was still the same.  It felt like the lymph-node in my armpit was swollen. Sunday (09/18/16)I no longer had any symptoms other than some mild injection site/shoulder pain. Today Monday (09/19/16) I feel like all symptoms have subsided.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Nausea, Oropharyngeal pain, Pyrexia, Somnolence
Clinical narrative: It started Thursday (09/15/16) evening with a headache and by Friday 09/16/16)morning, I had a sore throat, headache, fever (from 99.9-101), nauseous, sore joints, injection site/shoulder pain, extreme fatigue/sleepiness and achy all over.  Even my eyelashes hurt!   Saturday (09/17/16) at 830pm I started to feel better.  I still had a slight headache but no fever and the achiness was mostly gone.  The injection site/shoulder pain was still the same.  It felt like the lymph-node in my armpit was swollen. Sunday (09/18/16)I no longer had any symptoms other than some mild injection site/shoulder pain. Today Monday (09/19/16) I feel like all symptoms have subsided.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV9
Symptoms: Back pain, Computerised tomogram normal, Hypoaesthesia, Mobility decreased, Nuclear magnetic resonance imaging spinal normal
Clinical narrative: History of back pain this summer, 9/1/16 was playing cello for a few hours, developed sharp back pain without radiation, and tingling distal to knee. Entire left leg was numb to touch and not able to move ankle. Was hospitalized x 3 days, followed by neuro, leg remains numb below knee. Receiving physical therapy.
Age: 16.0
Sex: F
Vaccine: HEPA, HPV9
Symptoms: Paraesthesia, Scan normal
Clinical narrative: History of back pain this summer, 9/1/16 was playing cello for a few hours, developed sharp back pain without radiation, and tingling distal to knee. Entire left leg was numb to touch and not able to move ankle. Was hospitalized x 3 days, followed by neuro, leg remains numb below knee. Receiving physical therapy.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Pruritus
Clinical narrative: Severe itching - Patient is taking Benadryl and contacting the Dr.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood pressure abnormal, Hypertension, Hypoaesthesia, Hypotension, Loss of consciousness
Clinical narrative: This spontaneous report has been received from a 69 year old male patient, who was reporting on himself. The patient had a prior history of shingles. The patient had no drug reactions or allergies. Between May and June 2015, the patient was vaccinated in the left arm with an unknown dose of ZOSTAVAX as his healthcare professional (HCP) advised him to get the vaccination to prevent shingles to reappear (route, lot # and expiry date were not reported). Concomitant therapies included Aspirin (manufacturer unknown) and Vitamin B complex. In 2015, one week after vaccination, the patient experienced a slight itching reaction (did not disclose where the itching was), his blood pressure was either too high or too low and it became so low to the point that he passed out, he also had extreme numbness in his arms and legs and he definitely could not feel them. The patient did not seek medical attention and no treatment was given for the event. No lab diagnostics studies were performed. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Upon internal review, the event of passed out was considered to be medically significant. Additional information is not expected as the reporter did not wish to be contacted.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: This spontaneous report has been received from a 69 year old male patient, who was reporting on himself. The patient had a prior history of shingles. The patient had no drug reactions or allergies. Between May and June 2015, the patient was vaccinated in the left arm with an unknown dose of ZOSTAVAX as his healthcare professional (HCP) advised him to get the vaccination to prevent shingles to reappear (route, lot # and expiry date were not reported). Concomitant therapies included Aspirin (manufacturer unknown) and Vitamin B complex. In 2015, one week after vaccination, the patient experienced a slight itching reaction (did not disclose where the itching was), his blood pressure was either too high or too low and it became so low to the point that he passed out, he also had extreme numbness in his arms and legs and he definitely could not feel them. The patient did not seek medical attention and no treatment was given for the event. No lab diagnostics studies were performed. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was not reported. Upon internal review, the event of passed out was considered to be medically significant. Additional information is not expected as the reporter did not wish to be contacted.
Sex: F
Vaccine: PPV
Symptoms: Adverse event, Extra dose administered
Clinical narrative: Information has been received from a male consumer referring to his mother, a female patient of unknown age. The patient's medical history, concurrent condition and concomitant medication were not reported. At an unspecified time, the patient received the first dose of PNEUMOVAX 23 (lot #, expiration date, dose and route unknown) at an unspecified location. Four weeks after the first PNEUMOVAX 23 vaccine, the patient was administered a second PNEUMOVAX 23 vaccine at an unspecified hospital. It could not be confirmed how, when, why, or for how long the patient was at the hospital to receive the second dose of PNEUMOVAX 23, therefore a complete adverse event report was completed. It was reported that the patient did not seek medical attention. The outcome of the event was unknown. The causal relationship between the event and PNEUMOVAX 23 was not reported. Additional information is not expected as the reporter declined to supply any demographic data for the patient or the patient's physician.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Guillain-Barre syndrome
Clinical narrative: Pt hospitalized and diagnosed with Guillain-Barre.
Age: 50.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site nodule
Clinical narrative: Localized at injection site. Patient described it as a "knot". Patient was instructed to keep warm compress on it so "knot" would go down. And problems (if patient was to get worse) or complications patient was instructed to call pharmacy and family doctor. Follow up will continue with patient.
Age: 86.0
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site bruising, Injection site haemorrhage, Injection site swelling, Skin discolouration
Clinical narrative: Left Deltoid, blood flow controlled by gauze compress. Bleeding stopped within minutes. Immediate onset of  swelling from injection site to the elbow. Injection site bruising, purple and black discoloration. Patient was monitored one on one for 20 minutes. On 9/17/2016 patient states the swelling has reduced and no c/o pain or discomfort in the arm.
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Asthenia, Confusional state, Disorientation, Headache, Insomnia
Clinical narrative: Patient became ill and no one knew why, Fever muscle aches and very weak. She tried to push through but couldn't. She started having a headache and could not sleep, just when she thought she was feeling better her condition worsen. We took her to the emergency twice . She became extremely confused and disorientated . They then admitted her for observation to the Medical Center and after days of trying to find the piece to the puzzle and answer came. Patient had a shot on Friday when she went to her medical doctor and the shot was a tainted batch or it was just a sever reaction to the medication which became toxic in her body and brain. i thought The doctors were  trying to set a course of seeing if there is a reversal shot or a needed  blood infusion. But, nothing of that sort has been done.  They have just kept her hospitalized  and are not running the needed test to set a course or action. My sister was completely fine up until the point she has the TDap vaccine. She is still the the hospital and the doctors are ignoring that fact that the vaccine had something to do with my sister's newly discovered conditions. Please I Beg you guys to help my sister. Because the doctors are not!
Age: 27.0
Sex: F
Vaccine: TDAP
Symptoms: Malaise, Myalgia, Pyrexia, Toxicity to various agents
Clinical narrative: Patient became ill and no one knew why, Fever muscle aches and very weak. She tried to push through but couldn't. She started having a headache and could not sleep, just when she thought she was feeling better her condition worsen. We took her to the emergency twice . She became extremely confused and disorientated . They then admitted her for observation to the Medical Center and after days of trying to find the piece to the puzzle and answer came. Patient had a shot on Friday when she went to her medical doctor and the shot was a tainted batch or it was just a sever reaction to the medication which became toxic in her body and brain. i thought The doctors were  trying to set a course of seeing if there is a reversal shot or a needed  blood infusion. But, nothing of that sort has been done.  They have just kept her hospitalized  and are not running the needed test to set a course or action. My sister was completely fine up until the point she has the TDap vaccine. She is still the the hospital and the doctors are ignoring that fact that the vaccine had something to do with my sister's newly discovered conditions. Please I Beg you guys to help my sister. Because the doctors are not!
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Facial paralysis, Hypoaesthesia, Swelling face
Clinical narrative: Woke up feeling numbness and swelling in left side of face.  Went to emergency department and was told it was not a stroke but have been diagnosed as having Bell's Palsey.  This did develop from a reaction to the flu shot.
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Unevaluable event
Clinical narrative: NO REACTIONS.
Age: 78.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site warmth
Clinical narrative: Soreness in upper arm around area receiving vaccine. Following day redness around area and following down inner part of arm almost to elbow. Area was hot to touch. Two days following vaccine reported to Pharmacy where vaccine given. Note made to my record. Soreness started to subside. By day four, all soreness and redness gone.
Age: 92.0
Sex: M
Vaccine: FLU3
Symptoms: Blood test, Chest pain, Pyrexia
Clinical narrative: Chest pain in AM and fever in PM (103 degrees).
Age: 74.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Injection site swelling
Clinical narrative: Flu like symptoms. Swelling at injection site.
Age: 38.0
Sex: F
Vaccine: FLU4
Symptoms: Axillary pain, Lymphadenopathy, Neck pain, Pain in extremity, Swelling
Clinical narrative: Patient received flu vaccine in rt deltoid per her report. States she noticed swelling and pain under rt arm pit which radiated to her neck and down her left arm.
Age: 84.0
Sex: F
Vaccine: FLU3
Symptoms: Infection, Injection site pruritus, Injection site rash, Rash
Clinical narrative: Patient noticed rash on arm near injection site 1-2 days after vaccine. Said she itched area. Then rash went down arm. Advised patient to see MD. Patient went to back in clinic patient first. They gave her antibiotic. No steroid. Said to follow up with them. Patient previously used ice at first. Partial itching area may have caused infection.
Age: 73.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Injection site erythema, Injection site nodule, Injection site pruritus, Injection site rash
Clinical narrative: Generalized itching and rash hard and red at injection site.
Age: 68.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: 6 cm diameter of Erythema and pruritus at injection site.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Oropharyngeal pain
Clinical narrative: Severe throat pain.
Age: 73.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Patient experienced pain, redness, and swelling in the arm where the vaccine was administered.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Arthralgia, Bedridden, Laboratory test, Pain
Clinical narrative: Pain started in her wrist on 6/8/16 and every day thereafter pain in another joint. By 7th day she was completely bedridden in extreme pain. Took her to several Drs and hospitals still no answers and still no improvement.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Arthralgia, Bedridden, Blood test, Computerised tomogram, Lumbar puncture
Clinical narrative: Pain started in her wrist on 6/8/16 and every day thereafter pain in another joint. By 7th day she was completely bedridden in extreme pain. Took her to several Drs and hospitals still no answers and still no improvement.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Nuclear magnetic resonance imaging, Pain, Single photon emission computerised tomogram
Clinical narrative: Pain started in her wrist on 6/8/16 and every day thereafter pain in another joint. By 7th day she was completely bedridden in extreme pain. Took her to several Drs and hospitals still no answers and still no improvement.
Age: 29.0
Sex: M
Vaccine: FLU3, PNC13
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: No adverse event - just received vaccine that he should not have received. He should have gotten the Pneumovax23 and instead got PREVENAR 13.
Age: 1.25
Sex: F
Vaccine: FLU4, HEPA, VARCEL
Symptoms: Rash erythematous, Rash maculo-papular
Clinical narrative: Developed bright red rash, on face, legs, buttock and maculopapular rash on chest anter body within minutes after vaccines given. Rash resolved spontaneously in 15-20 min.